{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:21:25Z","timestamp":1790979685155,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jaci.2018.03.014","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T04:29:32Z","timestamp":1524716972000},"page":"1818-1830.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects"],"prefix":"10.1016","volume":"142","author":[{"given":"Ken","family":"Muramatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ujiie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nishie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Natsuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.03.014_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","article-title":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3","volume":"22","author":"Fontenot","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.03.014_bib3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaci.2018.03.014_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.03.014_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.03.014_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2018.03.014_bib9","doi-asserted-by":"crossref","first-page":"19042","DOI":"10.1073\/pnas.1313547110","article-title":"B cells are critical for autoimmune pathology in Scurfy mice","volume":"110","author":"Aschermann","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2018.03.014_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13075-015-0538-0","article-title":"Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease","volume":"17","author":"Hadaschik","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2018.03.014_bib11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2005.08.047","article-title":"Role of regulatory T cells in human diseases","volume":"116","author":"Chatila","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib12","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4049\/jimmunol.1501774","article-title":"\u03b3\u03b4 T cells protect the liver and lungs of mice from autoimmunity induced by scurfy lymphocytes","volume":"196","author":"Ujiie","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/jid.2010.16","article-title":"Autoantibodies in scurfy mice and IPEX patients recognize keratin 14","volume":"130","author":"Huter","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib14","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.151.10.5742","article-title":"Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain","volume":"151","author":"Giudice","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clindermatol.2013.01.006","article-title":"Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies","volume":"31","author":"Lo Schiavo","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaut.2013.08.010","article-title":"Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals","volume":"50","author":"Mayer","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2018.03.014_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2018.03.014_bib19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jmg.38.12.874","article-title":"Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX)","volume":"38","author":"Kobayashi","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaci.2018.03.014_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.140.4.466","article-title":"Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"140","author":"Nieves","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2011.05.010","article-title":"Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3","volume":"141","author":"Kobayashi","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0923-1811(99)00019-5","article-title":"Acquired skin disease of hemidesmosomes","volume":"20","author":"Zillikens","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2018.03.014_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2018.03.014_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.200012098","article-title":"The BPAG1 locus: alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles","volume":"154","author":"Leung","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2018.03.014_bib25","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.03.014_bib26","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.4049\/jimmunol.153.8.3764","article-title":"CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse","volume":"153","author":"Blair","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib27","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"B\u00fcdinger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.03.014_bib28","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/eji.201242391","article-title":"Type-1 immunity drives early lethality in scurfy mice","volume":"42","author":"Suscovich","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib29","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1038\/ncomms8997","article-title":"Batf is important for IL-4 expression in T follicular helper cells","volume":"6","author":"Sahoo","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2018.03.014_bib30","doi-asserted-by":"crossref","first-page":"e68145","DOI":"10.1371\/journal.pone.0068145","article-title":"Follicular helper T cells (Tfh) and IL-21 involvement in the pathogenesis of bullous pemphigoid","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.03.014_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2018.03.014_bib32","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.03.014_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/2326-6066.CIR-15-0123","article-title":"Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PD-1 and PD-L1","volume":"4","author":"Naidoo","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaci.2018.03.014_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cup.12735","article-title":"Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma","volume":"43","author":"Mochel","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaci.2018.03.014_bib35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/cup.12717","article-title":"Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions","volume":"43","author":"Jour","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaci.2018.03.014_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cup.12858","article-title":"Diverse types of dermatologic toxicities from immune checkpoint blockade therapy","volume":"44","author":"Curry","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaci.2018.03.014_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaad.2005.08.047","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature","volume":"55","author":"McGinness","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib38","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jaci.2005.08.046","article-title":"Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice","volume":"116","author":"Lin","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jdermsci.2013.12.001","article-title":"Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII","volume":"73","author":"Nishie","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2018.03.014_bib40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjd.12936","article-title":"BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?","volume":"171","author":"Schmidt","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2133.2009.09266.x","article-title":"IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses","volume":"161","author":"Feliciani","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib42","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/bjd.13874","article-title":"Significantly higher prevalence of circulating bullous pemphigoid-specific IgG autoantibodies in elderly patients with a nonbullous skin disorder","volume":"173","author":"Meijer","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib43","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database","volume":"175","author":"B\u00e9n\u00e9","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib45","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib46","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1172\/JCI116368","article-title":"Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome","volume":"91","author":"Ishiko","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2018.03.014_bib47","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.humimm.2014.01.005","article-title":"IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice","volume":"75","author":"Feldrihan","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib48","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2174\/1381612033454379","article-title":"Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications","volume":"9","author":"Ruiz-Arguelles","year":"2003","journal-title":"Curr Pham Des"},{"key":"10.1016\/j.jaci.2018.03.014_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2004.09.007","article-title":"Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230","volume":"24","author":"Kiss","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2018.03.014_bib50","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2340\/00015555-1848","article-title":"Characterization of two cases of bullous pemphigoid reactive only with BP230 on Japanese enzyme-linked immunosorbent assays","volume":"94","author":"Sasai","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2018.03.014_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/1346-8138.12848","article-title":"Case of burn-associated bullous pemphigoid caused by anti-BP230 immunoglobulin G autoantibodies","volume":"42","author":"Morita","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1684\/ejd.2015.2719","article-title":"Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins","volume":"26","author":"Hayakawa","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib53","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.4049\/jimmunol.1003402","article-title":"Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner","volume":"188","author":"Natsuga","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.03.014_bib54","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jid.2015.11.030","article-title":"Epitope-dependent pathogenicity of antibodies targeting a major bullous pemphigoid autoantigen collagen XVII\/BP180","volume":"136","author":"Wada","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1468-3083.2009.03480.x","article-title":"Basement membrane antibodies in sera of haematopoietic cell recipients are associated with graft-versus-host disease","volume":"24","author":"Hofmann","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2018.03.014_bib56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2230.2005.01866.x","article-title":"Erosive lichen planus of the vulva: weak circulating basement membrane zone antibodies are present","volume":"30","author":"Cooper","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib57","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.immuni.2017.07.008","article-title":"Analyses of a mutant Foxp3 allele reveal BATF as a critical transcription factor in the differentiation and accumulation of tissue regulatory T cells","volume":"47","author":"Hayatsu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2018.03.014_bib58","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.200012098","article-title":"The BPAG1 locus: alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles","volume":"154","author":"Leung","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2018.03.014_bib59","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.jid.2017.07.831","article-title":"C-terminal processing of collagen XVII induces neoepitopes for linear IgA dermatosis autoantibodies","volume":"137","author":"Toyonaga","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.03.014_bib60","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ajpath.2015.01.012","article-title":"Context-dependent regulation of collagen XVII ectodomain shedding in skin","volume":"185","author":"Nishie","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2018.03.014_bib61","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918306158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918306158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:16:29Z","timestamp":1758791789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918306158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0091674918306158"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.03.014","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733126253.793545518","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}